Bristol-Myers Squibb
BMY
#167
Rank
โ‚ฌ103.81 B
Marketcap
50,98ย โ‚ฌ
Share price
2.70%
Change (1 day)
-4.84%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2025 (TTM): 3,03ย โ‚ฌ

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is 2,99ย โ‚ฌ. an increase over its 2024 EPS that were of -3,82ย โ‚ฌ.

EPS history for Bristol-Myers Squibb from 2012 to 2025

Annual EPS

Year EPS Change
20252,98ย โ‚ฌ-178.05%
2024-3,82ย โ‚ฌ-213.92%
20233,36ย โ‚ฌ30.2%
20222,58ย โ‚ฌ-6.04%
20212,74ย โ‚ฌ-179.29%
2020-3,46ย โ‚ฌ-281%
20191,91ย โ‚ฌ-27.06%
20182,62ย โ‚ฌ
20162,31ย โ‚ฌ175.26%
20150,84ย โ‚ฌ-19.83%
20141,05ย โ‚ฌ-22.44%
20131,35ย โ‚ฌ34.48%
20121,00ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
9,63ย โ‚ฌ 221.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
6,23ย โ‚ฌ 108.09%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
1,18ย โ‚ฌ-60.69%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
2,07ย โ‚ฌ-30.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
19,91ย โ‚ฌ 565.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
12,39ย โ‚ฌ 314.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1,79ย โ‚ฌ-40.31%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
7,64ย โ‚ฌ 155.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
6,32ย โ‚ฌ 111.28%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
5,13ย โ‚ฌ 71.39%๐Ÿ‡ฌ๐Ÿ‡ง UK